Related Experiment Video
Updated: May 24, 2026
07:30
Design of Cecal Ligation and Puncture and Intranasal Infection Dual Model of Sepsis-Induced Immunosuppression
Published on: June 15, 2019
New insights into chronic inflammation-induced immunosuppression
Julia Kanterman1, Moshe Sade-Feldman, Michal Baniyash
1The Lautenberg Center for General and Tumor Immunology, The Hebrew University-Hadassah Medical School, Jerusalem, Israel.
Seminars in Cancer Biology
|March 6, 2012
Summary
Chronic inflammation suppresses immune cells like natural killer (NK) and T cells, hindering cancer therapies. Resolving this immunosuppression is key to enhancing treatment success and disease regression.
Area of Science:
- Immunology
- Oncology
- Pathology
Background:
- Chronic inflammation links diverse pathologies including cancer, autoimmune diseases, and infections.
- Immune cells such as natural killer (NK) cells and T cells become suppressed during chronic inflammation.
- This suppressive environment, driven by factors like cytokines and transcription factors (NFκB, STAT3), impedes therapeutic success.
Purpose of the Study:
- To review the interplay between chronic inflammation and induced immunosuppression.
- To explore therapeutic strategies targeting inflammation-induced immunosuppression in cancer, autoimmune diseases, and transplantation.
- To emphasize the need for biomarkers to personalize immune interventions.
Main Methods:
- Literature review and synthesis of current evidence.
- Analysis of the mechanisms driving inflammation-induced immunosuppression.
- Discussion of potential immune interventions and therapeutic strategies.
Main Results:
- Chronic inflammation creates a suppressive milieu that limits conventional and immune-based therapies.
- Targeting inflammation and immunosuppression can enhance disease regression and treatment efficacy.
- Biomarkers are crucial for evaluating immune status and tailoring personalized treatments.
Conclusions:
- Resolving chronic inflammation-induced immunosuppression is vital for improving therapeutic outcomes in various diseases.
- Harnessing or combating immunosuppression offers promising avenues for treating cancer, autoimmune conditions, and facilitating transplantation.
- Personalized medicine approaches, guided by immune status biomarkers, are essential for optimal treatment.
Related Concept Videos
01:12Chronic Inflammation: Introduction
Chronic inflammation is a prolonged, dysregulated immune response that persists for weeks to years when the inciting stimulus is difficult to eradicate or when self‑antigens drive ongoing reactivity. Morphologically, it is defined by mononuclear cell infiltration, progressive tissue destruction, and concurrent attempts at healing via angiogenesis and fibrosis. Compared with acute inflammation, edema is less prominent while cellular infiltration predominates; triggers include persistent...
01:25Inflammatory Bowel Disease III: Crohn's Disease
Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
01:28Inflammatory Response
An inflammatory response is a localized, nonspecific immune reaction that occurs when a tissue is injured. It is characterized by redness, swelling, heat, and pain, which are commonly called the cardinal signs and symptoms of inflammation. Inflammation can sometimes result in a loss of function.
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
01:24T Cell Types and Functions
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
01:27Cytotoxic T Cells-mediated Immune Response
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
01:29Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel Disease...